MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Femara More Effective Than Nolvadex

Back to breast cancer blog Blogs list Cancer blog  


Subscribe To Breast Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Femara More Effective Than Nolvadex

Femara More Effective Than Nolvadex
Scientists affiliated with the BIG-98 trial comparing Femara® (letrozole) to Nolvadex® (tamoxifen) have reported that longer follow-up confirms the superiority of Femara in postmenopausal women with early, hormone-positive breast cancer. The details of this follow-up study were presented at the 2006 annual European Society for Medical Oncology (ESMO) meeting in Istanbul in October.

Femara is an aromatase agent that is approved for first-line therapy of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced breast cancer; metastatic breast cancer; advanced breast cancer in postmenopausal women with disease progression following anti-estrogen treatment; and as neo-adjuvant treatment. It is also approved for extended adjuvant treatment in early breast cancer, following 5 years of therapy with Nolvadex, based on phase III clinical trial results. Several clinical trials are ongoing to help elucidate optimal timing and/or sequencing of aromatase agents and Nolvadex in the therapy of hormone-positive women with breast cancer in the adjuvant setting, and it appears that aromatase agents are providing superior results to those of Nolvadex in several settings in the therapy of hormone-positive breast cancer.


Posted by: Janet    Source




Did you know?
Scientists affiliated with the BIG-98 trial comparing Femaraandreg; (letrozole) to Nolvadexandreg; (tamoxifen) have reported that longer follow-up confirms the superiority of Femara in postmenopausal women with early, hormone-positive breast cancer. The details of this follow-up study were presented at the 2006 annual European Society for Medical Oncology (ESMO) meeting in Istanbul in October.

Medicineworld.org: Femara More Effective Than Nolvadex

BREAST CANCER MAIN| Home| Breast cancer news| Common terms| Breast cancer treatment| Breast cancer treatment by stage| Mammogram and breast cancer screening| Surgical treatment of breast cancer| Chemotherapy of breast cancer| Chemo drugs used in breast cancer| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy of breast cancer| Radiation therapy of breast cancer| Monoclonal therapy| High dose chemotherapy for breast cancer| Recurrent breast cancer| Bisphosphonates and breast cancer| Pregnancy and breast cancer| Risk factors for breast cancer| Risk details| My risk| Comprehensive breast cancer information| Breast cancer statistics| African Americans and breast cancer| Ashkenazi and breast cancer| Asians| Hispanic| Men| Native Americans| Older women and breast cancer| Younger women| Pregnant women and breast cancer| BRCA|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.